ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma.

Sakiko Harada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.